New drug duo aims to control advanced colon cancer
Disease control
Ongoing
This study tests two drugs, botensilimab and balstilimab, in 16 people with advanced colorectal cancer that has spread. The goal is to see if the combination can shrink or stabilize tumors. If the cancer worsens, standard chemotherapy is added. Participants are followed for up to…
Phase: PHASE2 • Sponsor: Nicholas DeVito, MD • Aim: Disease control
Last updated May 13, 2026 16:03 UTC